Non-invasive bioluminescence imaging of β-cell function in obese-hyperglycemic [ob/ob] mice

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Patel, Manishkumar ^a   Gleason, Alexa ^a   O'Malley, Stacey ^a   Connolly, Brett ^a   Suresch, Donna ^a   Virostko, John ^b   Phillips, Neil ^c   Lin, Shu An ^a   Chen, Tsing Bau ^a   Klimas, Michael ^a   Hargreaves, Richard J ^a   Sur, Cyrille ^a   Williams, David L ^a   Powers, Alvin C ^c,d,e   Bednar, Bohumil ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HYPERGLYCEMIA; LUMINESCENCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET; PATHOPHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; ISLETS OF LANGERHANS; LUMINESCENCE; MICE; OBESITY;

EID: 84908667408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106693     Document Type: Article

References (29)

1. Marchetti P, Lupi R, Del Guerra S, Bugliani M, Marselli L, et al. (2010) The beta-cell in human type 2 diabetes. Adv Exp Med Biol 654: 501-514.
2. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, et al. (2004) Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 89: 5535-5541.
3. Lindstrom P (2010) beta-cell function in obese-hyperglycemic mice [ob/ob Mice]. Adv Exp Med Biol 654: 463-477.
4. Lin PY, Romsos DR, Leveille GA (1977) Food intake, body weight gain, and body composition of the young obese (ob/ob) mouse. J Nutr 107: 1715-1723.
5. Loten EG, Le Marchand Y, Assimacopoulos-Jeannet F, Denton RM, Jeanrenaud B (1976) Does hyperinsulinemia in ob/ob mice cause an insulinstimulated adipose tissue? Am J Physiol 230: 602-607.
6. Le Marchand Y, Loten EG, Assimacopoulos-Jeannet F, Forgue ME, Freychet P, et al. (1977) Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects. Diabetes 26: 582-590.
7. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, et al. (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523-531.
8. Virostko J, Chen Z, Fowler M, Poffenberger G, Powers AC, et al. (2004) Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants. Mol Imaging 3: 333-342.
9. Virostko J, Jansen ED, Powers AC (2006) Current status of imaging pancreatic islets. Curr Diab Rep 6: 328-332.
10. Virostko J, Powers AC, Jansen ED (2007) Validation of luminescent source reconstruction using single-view spectrally resolved bioluminescence images. Appl Opt 46: 2540-2547.
11. Park SY, Wang X, Chen Z, Powers AC, Magnuson MA, et al. (2005) Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis 43: 80-86.
12. Park SY, Bell GI (2009) Noninvasive monitoring of changes in pancreatic betacell mass by bioluminescent imaging in MIP-luc transgenic mice. Horm Metab Res 41: 1-4.
13. Virostko J, Powers AC (2009) Molecular imaging of the pancreas in small animal models. Gastroenterology 136: 407-409.
14. Virostko J, Radhika A, Poffenberger G, Chen Z, Brissova M, et al. (2009) Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation. Mol Imaging Biol 12: 42-53.
15. Brissova M, Fowler M, Wiebe P, Shostak A, Shiota M, et al. (2004) Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53: 1318-1325.
16. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, et al. (2002) Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277: 11225-11232.
17. Wang T, Lacik I, Brissova M, Anilkumar AV, Prokop A, et al. (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 15: 358-362.
18. Hummel KP, Coleman DL, Lane PW (1972) The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem Genet 7: 1-13.
19. Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, et al. (2004) Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145: 3258-3264.
20. Barros CC, Almeida SS, Mori MA, Valero VB, Haro AS, et al. (2009) Efficient method for obtaining Lep(ob)/Lep(ob)-derived animal models using adipose tissue transplantations. Int J Obes (Lond) 33: 938-944.
21. Paroo Z, Bollinger RA, Braasch DA, Richer E, Corey DR, et al. (2004) Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3: 117-124.
22. Westman S (1968) Development of the obese-hyperglycaemic syndrome in mice. Diabetologia 4: 141-149.
23. Keyaerts M, Verschueren J, Bos TJ, Tchouate-Gainkam LO, Peleman C, et al. (2008) Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging 35: 999-1007.
24. Leckstrom A, Lundquist I, Ma Z, Westermark P (1999) Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 18: 266-273.
25. Jetton TL, Lausier J, LaRock K, Trotman WE, Larmie B, et al. (2005) Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 54: 2294-2304.
26. Bock T, Pakkenberg B, Buschard K (2003) Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52: 1716-1722.
27. Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, et al. (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53: 624-632.
28. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110.
29. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, et al. (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88: 2300-2308.